BXP
41
2
EIX
45
3
ECL
42
3
CSCO
58
2
SLG
48
2
SYF
62
4
ETR
65
5
CMCSA
49
4
T
65
2
SWKS
35
-7
HON
52
3
HPE
40
3
PRGO
29
4
MHK
48
3
MUR
27
5
COST
50
7
HAL
48
5
GM
35
2
SPG
43
3
AON
56
-6
BXP
41
2
EIX
45
3
ECL
42
3
CSCO
58
2
SLG
48
2
SYF
62
4
ETR
65
5
CMCSA
49
4
T
65
2
SWKS
35
-7
HON
52
3
HPE
40
3
PRGO
29
4
MHK
48
3
MUR
27
5
COST
50
7
HAL
48
5
GM
35
2
SPG
43
3
AON
56
-6
Financhill
Back

Sophia Genetics SA 10K Form

Sell
10

SOPH
Sophia Genetics SA

Last Price:
$2.69
Seasonality Move:
-18.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SOPH News And Ratings

See the #1 stock for the next 7 days that we like better than SOPH

SOPH Financial Statistics

Sales & Book Value

Annual Sales: $65.2M
Cash Flow: $-12.5M
Price / Cash Flow: 0
Annual Sales: $1.45
Price / Book: 1.96

Profitability

EPS (TTM): -0.95000
Net Income (TTM): $-62.5M
Gross Margin: $43.9M
Return on Equity: -50.8%
Return on Assets: -34.7%

Sophia Genetics SA Earnings Forecast

Key Sophia Genetics SA Financial Ratios

  • The Gross Profit Margin over the past 6 years for SOPH is 67.42%.
  • The Selling, General & Administrative Expenses for SOPH have been equal to 117.11% of Gross Profit Margin.
  • The Research & Development expenses have been 52.73% of Revenue.
  • The Net Earning history of SOPH is -95.89% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Sophia Genetics SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: SOPH
Website: sophiagenetics.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 3.71
Quick Ratio: 3.32

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SOPH Technical Analysis vs Fundamental Analysis

Sell
10
Sophia Genetics SA (SOPH) is a Sell

Is Sophia Genetics SA a Buy or a Sell?